U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. FDA Clinical Investigator Training Course (CITC) 2024 - 12/10/2024
  1. News & Events for Human Drugs

Conference | Virtual

Event Title
FDA Clinical Investigator Training Course (CITC) 2024
December 10 - 12, 2024


Date:
December 10 - 12, 2024
Day1:
- ET
Day2:
- ET
Day3:
- ET


AGENDA

Visit CDER Small Business and Industry Assistance Page

ABOUT THIS EVENT (Hosted by CDER SBIA)

The primary goal of this clinical investigator training course is to provide participants with the essential knowledge and skills to conduct clinical trials effectively, ethically, and in accordance with regulatory standards. The course aims to prepare clinical investigators to conduct high-quality research that contributes to scientific knowledge and improves patient care.

Participants will acquire a practical understanding of:

  • FDA’s approach to trial design
  • Statistical issues in the analysis of trial data
  • Safety concerns in the development of medical products
  • Understanding preclinical information relevant to medical product development
  • Clinical investigator responsibilities

INTENDED AUDIENCE

This clinical investigator training course is intended for all stakeholders in the clinical trial enterprise including industry, academia, and regulators (both domestic and foreign). The agenda is designed for:

  • Clinical investigators
  • Health care professionals (physicians, nurses, pharmacists, other healthcare workers), and
  • Individuals involved in biomedical research and the development of drugs and biological products

TOPICS COVERED

  • Study design and protocol development
  • Biostatistics and data analysis
  • Ethical considerations
  • Safety considerations for clinical trials
  • Data management and integrity
  • Regulatory requirements and compliance
  • Innovations in trial design and implementation

LEARNING OBJECTIVES

  • Understand key considerations for the design of clinical trials
  • Review statistical concepts relevant to the analysis and interpretation of clinical trial data
  • Explain the responsibilities of clinical investigators in the conduct of clinical trials
  • Understand FDA regulatory requirements and guidance related to the design and conduct of clinical trials

FDA RESOURCES

CONTINUING EDUCATION

Real-time attendance is required for the certificate of attendance which can be used in support of CEs for the following professional organizations. Certificates are only available during the two weeks post-event.

This course has been pre-approved by:

  • RAPS as eligible for a maximum of 12 credits for a two-day event (appropriate to real-time attendance) towards a participant’s RAC recertification upon full completion.
  • SOCRA who accepts documentation of candidate participation in continuing education programs for re-certification if the program is applicable to clinical research regulations, operations or management, or to the candidate's clinical research therapeutic area.
  • SQA as eligible for 1 non-GCP or non-GLP unit for every 1 hour of instructional time towards a participant’s RQAP re-registration.
  • ACRP for continuing education in clinical research. ACRP will provide 1 ACRP contact hour for every 45-60 minutes of qualified material.

TECHNICAL INFORMATION

  • To optimize your webinar experience, use Chrome when viewing Adobe Connect in a browser.
  • Please contact info@sbiaevents.com for all technical questions.
  • If you encounter any technical issues before or during the event, please visit the Technical Issues Support
  • Test your PC for use with Adobe Connect prior to the day of the event. Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.
Back to Top